Published in Neurology on July 05, 2006
Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol (2011) 2.55
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 2.03
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet (2008) 1.66
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology (2009) 1.24
PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero. Environ Health Perspect (2010) 1.21
Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol (2010) 1.20
Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2007) 1.07
Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology (2008) 1.05
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med (2013) 1.03
A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler (2008) 1.02
Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives. Int J Mol Sci (2013) 0.98
Familial amyotrophic lateral sclerosis, a historical perspective. Acta Myol (2011) 0.90
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. BMC Bioinformatics (2008) 0.89
Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet (2014) 0.87
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene (2015) 0.83
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Neurol Sci (2014) 0.82
Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis. BMC Med Genet (2009) 0.80
Susceptibility genes in sporadic ALS: separating the wheat from the chaff by international collaboration. Neurology (2006) 0.79
DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress. PLoS One (2014) 0.78
Amyotrophic lateral sclerosis and environmental factors. Funct Neurol (2016) 0.77
MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population. Neural Regen Res (2013) 0.76
A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Res (2015) 0.75
The paraoxonase disruption hypothesis in sporadic ALS steamrolled. Neurol Sci (2016) 0.75
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet (2001) 3.59
Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med (1991) 3.45
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke (2000) 2.06
Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta (1998) 1.77
Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia (2009) 1.70
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol (1997) 1.62
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology (1996) 1.50
Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J Neurochem (1999) 1.47
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol (2005) 1.45
GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD-1) gene. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 1.41
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31
Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet (1994) 1.28
Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci (1998) 1.21
Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology (2000) 1.16
Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes (2000) 1.12
Purification and partial characterization of the myelin-associated glycoprotein from adult rat brain. Biochim Biophys Acta (1983) 1.11
Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Ann Neurol (1998) 1.07
Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet (1995) 1.06
Biochemical demonstration of the myelin-associated glycoprotein in the peripheral nervous system. J Neurochem (1981) 1.05
Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther (1999) 1.04
Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport (2000) 1.03
Inoculation of containerized Pinus pinea L. seedlings with seven ectomycorrhizal fungi. Mycorrhiza (2001) 0.96
Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol (2006) 0.96
A two basepair deletion in the SOD 1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet (1994) 0.96
Quantitative detection of Lactarius deliciosus extraradical soil mycelium by real-time PCR and its application in the study of fungal persistence and interspecific competition. J Biotechnol (2006) 0.95
Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Dement Geriatr Cogn Disord (2009) 0.95
Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis. Exp Neurol (1998) 0.95
Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia (2012) 0.92
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis. Clin Genet (2006) 0.91
The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab (2009) 0.91
Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis. Neurochem Res (2006) 0.91
Clinical prediction of airways hyperresponsiveness. Chest (1988) 0.90
Serum albumin level and nosocomial pneumonia in stroke patients. Eur J Neurol (2006) 0.88
Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea. Diabet Med (2009) 0.88
Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology (1999) 0.88
Androgen receptor gene polymorphisms in amyotrophic lateral sclerosis. Neuromuscul Disord (1993) 0.87
Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes Metab (2011) 0.87
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology. Biol Psychiatry (1997) 0.86
"Pure" hereditary spastic paraplegias: the story becomes complicated. Neurology (1999) 0.86
Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes. Diabet Med (2013) 0.85
Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr (2007) 0.85
Experimental hyperphenylalaninemia: effect on central nervous system myelin subfractions. Exp Neurol (1980) 0.85
Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. AJNR Am J Neuroradiol (2007) 0.85
Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol (2013) 0.85
The effect of cysteine on L-alpha-glycerophosphate and lactate dehydrogenase reactions. J Biol Chem (1968) 0.85
Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology (1997) 0.85
Progressive multifocal leukoencephalopathy (PML) in a patient with silicosis treated previously with steroids. A report of a case with JC virus infection confirmed immunohistochemically and by electron microscopy. Pol J Pathol (2000) 0.84
Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain. Neuroscience (2000) 0.84
Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathol (1996) 0.84
Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology (1996) 0.83
A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease. Acta Neurol Scand (2008) 0.83
Interleukin 1beta-511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 0.83
Transient hyperglycemia in ischemic stroke patients. J Neurol Sci (2001) 0.83
DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology (2004) 0.83
The prognostic significance of microalbuminuria in non-diabetic acute stroke patients. Med Sci Monit (2001) 0.82
Gastric electromechanical dysfunction in Parkinson's disease. Funct Neurol (2000) 0.82
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse. Neurology (2010) 0.81
Early predictors of 30-day mortality in supratentorial ischemic stroke patients--first episode. Med Sci Monit (2001) 0.81
Clinical implications of the genetics of ALS and other motor neuron diseases. Neurology (2001) 0.81
Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population. Diabetes Metab (2006) 0.81
Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy. Neuroscience (2010) 0.81
[Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation]. Med Clin (Barc) (1999) 0.81
Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience. Clin Transl Oncol (2009) 0.80
Lack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke. J Neurol Neurosurg Psychiatry (2004) 0.80
[Effect of different storage conditions on the stability of aqueous solutions of chlorhexidine digluconate]. Acta Pol Pharm (1981) 0.80
Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group. Int J Clin Pract Suppl (1999) 0.80
ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand (2006) 0.80
1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia (2013) 0.80
Unverricht-Lundborg disease: absence of nonallelic genetic heterogeneity. Ann Neurol (1993) 0.79